[1] Pretini, V., Koenen, M.H., Kaestner, L., Fens, M.H.A.M., Schiffelers, R.M., Bartels, M., Van Wijk, R., 2019. Red blood cells: chasing interactions. Frontiers in Physiology 10, 945–962. [2] Dobkin, J., Mangalmurti, N.S., 2022. Immunomodulatory roles of red blood cells. Current Opinion in Hematology 29, 6, 306–309. [3] Richardson, K.J., Kuck, L., Simmonds, M.J., 2020. Beyond oxygen transport: active role of erythrocytes in the regulation of blood flow. American Journal of Physiology-Heart and Circulatory Physiology 319, 4, H866–H872. [4] Sturtzel, C., 2017. Endothelial Cells, In: The Immunology of Cardiovascular Homeostasis and Pathology, 71–91. [5] A. Alexandrova, N. Antonova, 2016. Correlation between erythrocyte aggregation and adhesion of leukocytes to the endothelium. Series on Biomechanics 30, 1, 35–42. [6] Muravyov, A. V., 2021. The role of gaseous mediators (CO, NO and H2S) in the regulation of blood circulation: analysis of the participation of blood cell microrheology. Regional Blood Circulation and Microcirculation 20, 1, 91–99. [7] Tikhomirova, I., Muravyov, A., Petrochenko, E., Malysheva, Yu., Petrochenko, A., 2022. Blood rheology and clotting in presence of gasotransmitters NO and H2S. Series on Biomechanics 36, 1, 53-60, DOI: 10.7546/SB.07.2022. [8] Sanikidze, T., Mantskava, M., Zvetkova, E., Antonova, N., 2022. Pharmacological analysis of the effectiveness of calcium blockers and NO synthesis modulators to correct arterial pressure during hemorrhagic shock. Series on Biomechanics 36, 1, 120-126. DOI: 10.7546/SB.16.2022. [9] Pereda, R., González, D., Rivero, H.B., Rivero, J.C., Pérez, A., Lopez, L.D.R., Mezquia, N., Venegas, R., Betancourt, J.R., Domínguez, R.E., Nodarse, H., 2020. Therapeutic Effectiveness of Interferon Alpha 2b Treatment for COVID-19 Patient Recovery. Journal of Interferon & Cytokine Research 40, 12, 578–588. [10] Gillies, M.C., Su, T., 1995. Interferon-α 2b Enhances Barrier Function of Bovine Retinal Microvascular Endothelium in Vitro. Microvascular Research 49, 3, 277–288. [11] Jones Buie, J.N., Oates, J.C., 2014. Role of Interferon Alpha in Endothelial Dysfunction: Insights Into Endothelial Nitric Oxide Synthase–Related Mechanisms. The American Journal of the Medical Sciences 348, 2, 168–175. [12] Scheglovitova, O.N., Romanov, Y.A., Maksianina, E. V., Kabaeva, N. V., Pronin, A.G., 2001. Herpes simplex type I virus infection of cultured human vascular endothelial cells: expression of cell adhesion molecules and induction of interferon and cytokine production by blood mononuclear cells. Russian Journal of Immunology: RJI: Official Journal of Russian Society of Immunology 6, 4, 367–376. [13] Lugovtsov, A.E., Gurfinkel, Y.I., Ermolinskiy, P.B., Maslyanitsina, A.I., Dyachuk, L.I., Priezzhev, A. V., 2019. Optical assessment of alterations of microrheologic and microcirculation parameters in cardiovascular diseases. Biomedical Optics Express 10, 8, 3974. [14] Semenov, A., Ermolinski, P., Yakimov, B., Lugovtsov, A., Shirshin, E., Muravyov, A., Shin, S., Wagner, C., V. Priezzhev, A., 2022. Changes in red blood cells biomechanical properties induced by albumin and fibrinogen membrane adsorption: A study using flow cytometry and optical tweezers. Series on Biomechanics 36, 1, 32-38 DOI: 10.7546/SB.04.2022. [15] Gomez, D., Reich, N.C., 2003. Stimulation of Primary Human Endothelial Cell Proliferation by IFN. The Journal of Immunology 170, 11, 5373–5381. [16] Gerber, S.A., Pober, J.S., 2008. IFN-α Induces Transcription of Hypoxia-Inducible Factor-1α to Inhibit Proliferation of Human Endothelial Cells. The Journal of Immunology 181, 2, 1052–1062. [17] Erdmann, J., Vitale, G., van Koetsveld, P.M., Croze, E., Sprij-Mooij, D.M., Hofland, L.J., van Eijck, C.H.J., 2011. Effects of Interferons α/β on the Proliferation of Human Micro- and Macrovascular Endothelial Cells. Journal of Interferon & Cytokine Research 31, 5, 451–458. [18] Jia, H., Thelwell, C., Dilger, P., Bird, C., Daniels, S., Wadhwa, M., 2018. Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy. Thrombosis Research 163, 105–116. [19] Özüyaman, B., Grau, M., Kelm, M., Merx, M.W., Kleinbongard, P., 2008. RBC NOS: regulatory mechanisms and therapeutic aspects. Trends in Molecular Medicine 14, 7, 314–322.
|
|